Loading clinical trials...

TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT04088760

TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders

The purpose of this study is to investigate the safety and efficacy of TCRαβ+/CD19+ depleted allogeneic hematopoietic stem cell transplant (HSCT) for malignant and non-malignant disorders in children ...

Lead sponsor: Children's Hospital Medical Center, Cincinnati•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation

NCT05501756 · Allogeneic Hematopoietic Cell Transplantation

TERMINATEDPhase 2

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT03720392 · Allogeneic Hematopoietic Cell Transplantation (HCT)

UNKNOWNPhase 2/3

HMA+DLI vs DLI Preemptive Therapy Based on MRD for AL Undergoing Allo-HSCT

NCT03662087 · Minimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell Transplantation

COMPLETED

Iron Overload in Patients Undergoing Donor Stem Cell Transplant

NCT00888316 · Cancer, Hematopoietic Stem Cell Transplantation, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 8, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment15

Start dateSep 2019

Last updatedSep 8, 2023

Condition

Allogeneic Hematopoietic Cell Transplantation

Locations shown

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 8, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions